Different studies, one evidence chain.
Enter through IIT and registrational support, then expand to cell-therapy and ATMP companies. Different studies feed one loop: the rules, cases and context each trial leaves behind are where the next one starts.
Registrational trials
Multi-centre trials with sponsors and CROs
Connect source materials, analyses and human sign-off in a traceable context for studies on the registration path.
Investigator-initiated trials
Start where the decision chain is shorter
Let teams focus on the science; data joins the same context graph instead of opening a new silo.
Cell-therapy and ATMP companies
Enterprise subscription and collaboration
New programmes and sites join one context graph; CRO / SMO channels then serve more research teams.
Where CROs fit
A CRO's work leaves with the contract. Helix sits on the sponsor's side of that line: every trial leaves rules, thresholds, eval cases and context behind, owned by the sponsor. CROs can work inside Helix; Helix is the memory those hands work from.